Table 6.
Discomfort | Sig. | Other Symptoms | Sig. | No Symptoms | Sig. | |||
---|---|---|---|---|---|---|---|---|
AOR [95% CI] | p-Value | AOR [95% CI] | p-Value | AOR [95% CI] | p-Value | |||
First Dose | Age: | ≤40 Yrs (vs. >40 Yrs) |
1.04 [0.71–1.52] | 0.850 | 1.45 [0.94–2.23] | 0.090 | 2.27 [1.47–3.52] | <0.0001 |
Gender: | Female (vs. Male) |
1.41 [0.99–2.01] | 0.060 | 1.16 [0.80–1.70] | 0.436 | 1.61 [1.05–2.48] | 0.029 | |
Second Dose | Age: | ≤40 Yrs (vs. >40 Yrs) |
1.41 [0.97–2.07] | 0.076 | 0.75 [0.47–1.22] | 0.246 | 2.01 [1.44–2.83] | <0.0001 |
Gender: | Female (vs. Male) |
1.52 [1.07–2.14] | 0.019 | 0.92 [0.58–1.46] | 0.724 | 1.68 [1.23–2.31] | 0.001 |